
USD $995.49
Rexigo contains Relugolix, which competitively binds to pituitary GnRH receptors to suppress luteinising hormone (LH) and follicle-stimulating hormone (FSH), rapidly lowering testosterone production that fuels prostate cancer growth.
It is indicated for adults with advanced or metastatic hormone-sensitive prostate cancer, often as part of androgen-deprivation therapy.
Generic Orgovyx (Relugolix) is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist used for the treatment of advanced prostate cancer in adult men. It works by rapidly reducing testosterone levels, which helps slow or stop the growth of prostate cancer cells that depend on testosterone for survival.
Unlike injectable hormone therapies, Generic Orgovyx is a once-daily oral tablet, offering convenience, faster testosterone suppression, and reduced cardiovascular risk in appropriate patients.
Oral, once-daily tablet (no injections required)
Rapid and sustained testosterone suppression
Effective in advanced and hormone-sensitive prostate cancer
Lower risk of major cardiovascular events compared to some injectable therapies
Non-invasive and patient-friendly treatment option
Cost-effective alternative to brand-name Orgovyx
Relugolix
Gonadotropin-Releasing Hormone (GnRH) Antagonist
Androgen Deprivation Therapy (ADT)
Generic Orgovyx is indicated for:
Advanced prostate cancer
Hormone-dependent prostate cancer
Androgen-sensitive prostate cancer (as directed by an oncologist or urologist)
Relugolix directly blocks GnRH receptors in the pituitary gland, which:
Inhibits luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release
Rapidly reduces testosterone production in the testes
Prevents testosterone-driven prostate cancer cell growth
Unlike GnRH agonists, Relugolix does not cause an initial testosterone surge, reducing the risk of symptom flare.
Recommended Dosage (Typical Regimen):
Loading dose: 360 mg (usually taken as three tablets) on Day 1
Maintenance dose: 120 mg orally once daily thereafter
✔ Take at the same time each day
✔ Can be taken with or without food
✔ Swallow tablets whole with water
Important: Dosage and duration must be determined by a healthcare professional.
Suitable for adult male patients:
Diagnosed with advanced or hormone-sensitive prostate cancer
Seeking an oral alternative to injectable hormone therapies
With cardiovascular risk factors (under medical guidance)
Do not use Generic Orgovyx if:
You are allergic to Relugolix or any component of the formulation
The patient is female or pediatric (not indicated)
You are taking strong P-gp inhibitors without medical advice
Always consult a healthcare provider before starting treatment.
Hot flashes
Fatigue
Diarrhea
Constipation
Decreased libido
Erectile dysfunction
Weight gain
Joint or muscle pain
Irregular heartbeat
Chest pain
Severe dizziness or fainting
Signs of liver problems (yellowing of skin/eyes)
Side effects are generally manageable and related to testosterone suppression.
Inform your doctor if you are taking:
Strong P-glycoprotein (P-gp) inhibitors or inducers
Antiarrhythmics
Other hormone therapies
Avoid starting or stopping medications without medical advice.
May affect heart rhythm (QT prolongation risk)
Testosterone suppression may impact bone density with long-term use
Regular monitoring of testosterone, PSA, and liver function is recommended
Use caution in patients with cardiovascular disease
Store at room temperature (20°C–25°C)
Keep away from moisture and direct sunlight
Keep out of reach of children